Nu Skin Enterprises Inc. (NUS)
NYSE: NUS
· Real-Time Price · USD
7.50
0.66 (9.65%)
At close: May 12, 2025, 3:36 PM
Nu Skin Enterprises Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|
| Nu Skin Revenue | 2.83M | 181.4M | 1.66B | 1.46B | 1.36B | 1.56B | 1.64B | 1.18B | 964.13M |
| Nu Skin Revenue Growth | -98.44% | -89.07% | +13.96% | +6.81% | -12.74% | -4.81% | +39.31% | +22.23% | n/a |
| Manufacturing Segment Revenue | 201.43M | 1.75B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Manufacturing Segment Revenue Growth | -88.51% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rhyz Other Segment Revenue | 85.19M | 35.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Rhyz Other Segment Revenue Growth | +141.92% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 286.35M | 283.23M | 283.38M | 278.11M | 326.36M | 318.63M | 322.21M | 322.02M | 328.69M | 354.46M | 360.99M | 391.25M | 427.47M | 416.86M | 446.7M | 443.55M | 464.75M | 445.75M | 400.18M | 355.67M | 388.11M | 379.88M | 395.27M | 408.31M | 432.32M | 437.18M | 452.88M | 410.95M | 418.62M | 378.5M | 363.84M | 341.57M | 362.03M | 395.93M | 392.47M | 325.81M | 389.05M | 376.01M | 378.14M | 369.63M |
| Selling, General, and Administrative Revenue Growth | +1.10% | -0.05% | +1.90% | -14.78% | +2.43% | -1.11% | +0.06% | -2.03% | -7.27% | -1.81% | -7.74% | -8.47% | +2.55% | -6.68% | +0.71% | -4.56% | +4.26% | +11.39% | +12.51% | -8.36% | +2.17% | -3.89% | -3.19% | -5.55% | -1.11% | -3.47% | +10.20% | -1.83% | +10.60% | +4.03% | +6.52% | -5.65% | -8.56% | +0.88% | +20.46% | -16.25% | +3.47% | -0.56% | +2.30% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | 22.6M | n/a | n/a | n/a | 23.3M | n/a | n/a | n/a | 27.2M | n/a | n/a | n/a | 23.3M | n/a | n/a | n/a | 30.1M | n/a | n/a | n/a | 23M | n/a | n/a | n/a | 22M | n/a | n/a | n/a | 24.3M | n/a | n/a | n/a | 20.1M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 165.42M | 167.61M | 165.46M | 153.54M | 181.33M | 187.75M | 185.16M | 188.12M | 201.03M | 216.48M | 219.43M | 242.7M | 260.83M | 255.72M | 277.89M | 273.75M | 284.13M | 280.69M | 248.63M | 206.04M | 228.13M | 231.94M | 245.83M | 249.71M | 269.05M | 271.51M | 272.76M | 257.7M | 265.38M | 235.28M | 228.35M | 209.01M | 222.89M | 255.27M | 248.36M | 195.56M | 237.66M | 240.26M | 239.45M | 234M |
| Sales and Marketing Revenue Growth | -1.31% | +1.30% | +7.76% | -15.32% | -3.42% | +1.40% | -1.57% | -6.42% | -7.14% | -1.34% | -9.59% | -6.95% | +2.00% | -7.98% | +1.51% | -3.65% | +1.22% | +12.90% | +20.67% | -9.68% | -1.64% | -5.65% | -1.55% | -7.19% | -0.90% | -0.46% | +5.84% | -2.89% | +12.79% | +3.04% | +9.26% | -6.23% | -12.69% | +2.78% | +27.00% | -17.71% | -1.08% | +0.34% | +2.33% | n/a |